drugset / Trial / NCT01317992

Ibudilast in the Treatment of Medication Overuse Headache

NCT01317992

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if ibudilast is effective in reverting patients with medication overuse headache suffering chronic daily headache back to their original episodic headache pattern.

Timeline

Start
2011-04
Primary completion
2013-06
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibudilast Small molecule 40 mg Oral

Indications

No indication recorded.